XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating activities      
Net income (loss) $ 200 $ (51) $ 233
Depreciation 365 345 322
Amortization 24 20 17
Amortization of deferred financing charges 6 8 6
Redemption premium on debt 21   7
Write-off of deferred financing costs 8 8 2
Earnings of affiliates, net of dividends received (10) 7 (9)
Stock compensation expense 17 14 19
Deferred income taxes (1) (35) (137)
Pension expense, net (1) 3 211
Gain on sale leaseback (66)    
Impairment of goodwill   51 6
Change in working capital (455) 47 (17)
Change in other noncurrent assets and liabilities (3) (20) (18)
Other, net 53 (11) (5)
Net cash provided by operating activities 158 386 637
Investing activities      
Purchases of property, plant and equipment (369) (326) (426)
Proceeds from sale of property, plant and equipment 85 11 7
Acquisition of businesses, net of cash acquired (18) (6) (668)
Investments in affiliates (23) (21) (4)
Purchases of marketable securities (32) (44) (33)
Proceeds from sales of marketable securities 30 5 6
Proceeds from maturities of marketable securities 35 36 29
Proceeds from sale of equity affiliate 29 21  
Proceeds from sale of subsidiaries, net of cash disposed (4)   1
Other, net   2 (15)
Net cash used in investing activities (293) (327) (1,123)
Financing activities      
Net change in short-term debt (3) 9 (3)
Proceeds from long-term debt 1,157 508 975
Repayment of long-term debt (1,156) (480) (423)
Redemption premium on debt (21)   (7)
Deferred financing payments (18) (13) (20)
Dividends paid to common stockholders (58) (15) (58)
Repurchases of common stock (23)   (25)
Distributions to noncontrolling interests (15) (11) (19)
Contributions from noncontrolling interests 14 4 4
Sale of interest to noncontrolling shareholder   9 53
Deconsolidation of non-wholly owned subsidiary (6) (14)  
Payments to acquire noncontrolling interests   (7)  
Other, net 2 (2) 2
Net cash provided by (used in) financing activities (127) (12) 479
Net increase (decrease) in cash, cash equivalents and restricted cash (262) 47 (7)
Cash, cash equivalents and restricted cash - beginning of period 567 518 520
Effect of exchange rate changes on cash balances (18) 2 5
Cash, cash equivalents and restricted cash - end of period 287 567 518
Not Designated as Hedging Instrument [Member]      
Investing activities      
Settlements of derivatives (4) $ (5) $ (20)
Currency Swap [Member]      
Investing activities      
Settlements of derivatives $ (22)